Targeting minimal residual disease: a path to cure?

Targeting minimal residual disease: a path to cure?

Therapeutics that block kinases, transcriptional modifiers, immune checkpoints and other biological vulnerabilities are transforming cancer treatment. As a result, many patients achieve dramatic responses, including complete radiographical or pathological remission, yet retain minimal residual disea...

Full description

Bibliographic Details
Main Authors: Luskin, Marlise R. (Author), Murakami, Mark A. (Author), Weinstock, David M. (Author), Manalis, Scott R (Contributor)
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering (Contributor), Massachusetts Institute of Technology. Department of Mechanical Engineering (Contributor), Program in Media Arts and Sciences (Massachusetts Institute of Technology) (Contributor)
Format: Article
Language:English
Published: Nature Publishing Group, 2018-11-06T15:18:56Z.
Subjects:
Article
Online Access:Get fulltext

Internet

Get fulltext

Similar Items